Bicalutamide-CYP 46 A 1 interactions 1 Binding of a Cyano-and Fluoro-Containing Drug Bicalutamide to Cytochrome P 450 46 A 1 : Unusual Features and Spectral Response *

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• In Silico and Intuitive Predictions of CYP46A1 Inhibition by Marketed Drugs with Subsequent Enzyme Crystallization in Complex with Fluvoxamine

  2012influential reference
• Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain.

  2011cited by this paper
• The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction.

  2011cited by this paper
• Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer.

  2011cited by this paper
• The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo

  2010cited by this paper
• Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain*

  2010cited by this paper
• Structural Basis for Three-step Sequential Catalysis by the Cholesterol Side Chain Cleavage Enzyme CYP11A1*

  2010cited by this paper
• Combined use of mass spectrometry and heterologous expression for identification of membrane-interacting peptides in cytochrome P450 46A1 and NADPH-cytochrome P450 oxidoreductase.

  2009cited by this paper
• Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain.

  2009cited by this paper
• Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1

  2008cited by this paper
• Cytochrome p450 and chemical toxicology.

  2008cited by this paper
• Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain

  2008cited by this paper
• Hierarchy of supramolecular synthons: persistent hydroxyl...pyridine hydrogen bonds in cocrystals that contain a cyano acceptor.

  2007cited by this paper
• Conformational polymorphism in bicalutamide.

  2007influential reference
• Brain cholesterol turnover required for geranylgeraniol production and learning in mice.

  2006cited by this paper
• Structure and chemistry of cytochrome P450.

  2005cited by this paper
• Structural basis for antagonism and resistance of bicalutamide in prostate cancer

  2005cited by this paper
• ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION

  2004cited by this paper
• Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain.

  2003cited by this paper
• cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain.

  1999cited by this paper
• Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation.

  1998cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• Enantioselective binding of Casodex to the androgen receptor.

  1996cited by this paper
• Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.

  1996cited by this paper
• High-resolution crystal structure of cytochrome P450cam.

  1987cited by this paper
• Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam.

  1987cited by this paper
• Crystal structure of substrate-free Pseudomonas putida cytochrome P-450.

  1986cited by this paper
• The influence of oxygen donor ligation on the spectroscopic properties of ferric cytochrome P-450: ester, ether and ketone co-ordination to the haem iron.

  1984influential reference
• Spectroscopic investigations of ferric cytochrome P-450-CAM ligand complexes. Identification of the ligand trans to cysteinate in the native enzyme.

  1982influential reference
• Formation of low spin complexes of ferric cytochrome P-450-CAM with anionic ligands. Spin state and ligand affinity comparison to myoglobin.

  1982influential reference
• Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species.

  1978cited by this paper
• Cytochrome P-450 difference spectra: effect of chemical structure on type II spectra in mouse hepatic microsomes.

  1974influential reference
• Effect of drug substrates on the reduction of hepatic microsomal cytochrome P-450 by NADPH.

  1968influential reference
• Spectral studies of drug interaction with hepatic microsomal cytochrome.

  1967cited by this paper
• Drug interaction with hepatic microsomal cytochrome.

  1966cited by this paper
• Biological Crystallography New Paradigm for Macromolecular Crystallography Experiments at Ssrl: Automated Crystal Screening and Remote Data Collection

  year unknowncited by this paper

• Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications

  2021cites this paper
• Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice

  2020cites this paper
• In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds

  2019cites this paper
• Marketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant Therapy

  2015cites this paper
• Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1

  2013cites this paper
• Stimulation of cerebral cholesterol turnover 1 Pharmacologic stimulation of cytochrome P 450 46 A 1 and cerebral cholesterol turnover in mice

  2013cites this paper